Routine utilization of machine perfusion in liver transplantation: Ready for prime time?

doi:10.3748/wjg.v30.i11.1488

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (940)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

530

Figures (1-1)

Sum=597

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=141

Publishing Process of This Article

Item

Count

Browse

Download

109

Sum=155

Mar 21, 2024 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Mar 21, 2024; 30(11): 1488-1493
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1488

Routine utilization of machine perfusion in liver transplantation: Ready for prime time?

Alessandro Parente, Keyue Sun, Philipp Dutkowski, AM James Shapiro, Andrea Schlegel

Alessandro Parente, AM James Shapiro, Department of Surgery, Division of Transplantation, University of Alberta Hospital, Edmonton T6G 2B7, Canada

Keyue Sun, Immunity and Inflammation, Lerner Research Institute, Cleveland, OH 44195, United States

Philipp Dutkowski, Swiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich 8091, Switzerland

Andrea Schlegel, Immunity and Inflammation, Digestive Disease and Surgery Institute, Cleveland, OH 44195, United States

Author contributions: Parente A and Schlegel A designed research; Parente A and Schlegel A wrote the manuscript; Sun K, Shapiro AMJ and Dutkowski P revised the manuscript. All authors approved the final version of the manuscript.

Conflict-of-interest statement: All authors declare no conflict of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Alessandro Parente, FEBS, MD, PhD, Surgeon, Department of Surgery, Division of Transplantation, University of Alberta Hospital, No. 8440 112 St NW, Edmonton T6G 2B7, Canada. aleparen@gmail.com

Received: January 3, 2024
Peer-review started: January 3, 2024
First decision: January 19, 2024
Revised: January 30, 2024
Accepted: February 28, 2024
Article in press: February 28, 2024
Published online: March 21, 2024

Core Tip

Core Tip: Machine perfusion (MP) has garnered the interest of the transplant community given its proven beneficial effects on the clinical outcomes after liver transplantation (LT). Herein, we discuss the historical background of MP in LT and the available clinical evidence. Furthermore, we highlighted the obstacles and the need for future research, in particular with respect to viability assessment and prolonged preservation times.